Menu

• Ask a Health Expert about HAEMOGLOBIN ABNORMAL
• Post Your Side Effect related to HAEMOGLOBIN ABNORMAL
• HAEMOGLOBIN ABNORMAL and FDA Warnings
• HAEMOGLOBIN ABNORMAL in Patients Wiki
• Report HAEMOGLOBIN ABNORMAL in Drug Side Effect Survey

HAEMOGLOBIN ABNORMAL side effect

What is HAEMOGLOBIN ABNORMAL ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Cytarabine Side Effects Report #5650470-6
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Mar 04, 2008. Male patient, weighting 67.46 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, pyrexia, . CYTARABINE dosage: 8800 MG. During the same period patient was treated with IDARUBICIN, LESTAURTINIB. Patient was hospitalized. Patient recovered.

Cytarabine Side Effects Report #5662172-0
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 10, 2008. Male patient, weighting 67.46 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, hyperglycaemia, hyperkalaemia, hypokalaemia, mucosal inflammation, platelet function test abnormal, . CYTARABINE dosage: 8800 MG. During the same period patient was treated with IDARUBICIN, LESTAURTINIB, AMBISOME. Patient recovered.

Revlimid Side Effects Report #5618728-4
Health Professional from UNITED STATES reported REVLIMID problem on Jan 30, 2008. Male patient, 69 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, platelet disorder, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 01/25/2008.

Pegatron Side Effects Report #5622952-4
PEGATRON problem was reported by a Physician from NEW ZEALAND on Feb 05, 2008. Male patient, 52 years of age, was diagnosed with hepatitis and was treated with PEGATRON. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, neutrophil count increased, subarachnoid haemorrhage, white blood cell count increased, . PEGATRON dosage: 100 MCG; QW; SC; 800 MG; QD; PO. Patient was hospitalized. Patient recovered.


Sorafenib Side Effects Report #5627828-4
Consumer or non-health professional from UNITED STATES reported SORAFENIB problem on Feb 12, 2008. Female patient was diagnosed with prostate cancer and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG. Patient recovered.

Olanzapine Side Effects Report #5531480-6
OLANZAPINE problem was reported by a Physician from FINLAND on Nov 21, 2007. Female patient was diagnosed with paranoia, anxiety, bipolar disorder, pain in extremity, prophylaxis urinary tract infection, thrombosis prophylaxis, osteoarthritis, urinary retention and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, lymphocyte count abnormal, neutrophil count decreased, platelet count decreased, white blood cell count decreased, . OLANZAPINE dosage: 5 MG, DAILY (1/D). During the same period patient was treated with OPAMOX, QUETIAPINE FUMARATE, OXYCONTIN, HIPREX, PRIMASPAN, PREDNISOLONE, DETRUSITOL, PANTOPRAZOLE. Patient recovered.

Tracleer Side Effects Report #5515943-5
Physician from GERMANY reported TRACLEER problem on Oct 29, 2007. Male patient, 25 years of age, was diagnosed with pulmonary hypertension and was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, hypoglycaemia, right ventricular failure, . TRACLEER dosage: 62.5 MG, BID, ORAL. During the same period patient was treated with JODTHYROX, ISOPTIN. Patient was hospitalized. Patient recovered.

Cisplatin Side Effects Report #5484030-7
CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 09, 2007. Female patient, weighting 132.9 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, neutrophil count abnormal, platelet count abnormal, vaginal haemorrhage, white blood cell count abnormal, . CISPLATIN dosage: 78.5 MG. During the same period patient was treated with TOPOTECAN. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5443340-X
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Aug 31, 2007. Female patient, weighting 148.8 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, neutrophil count abnormal, platelet count abnormal, white blood cell count abnormal, . CYCLOPHOSPHAMIDE dosage: 1050 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient recovered.


Quetiapine Side Effects Report #5730445-9
QUETIAPINE FUMARATE problem was reported by a Health Professional from UNITED KINGDOM on Apr 29, 2008. Male patient, 62 years of age, weighting 114.6 lb, was diagnosed with bipolar disorder, diabetes mellitus, depression and was treated with QUETIAPINE FUMARATE. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, neutrophil count abnormal, red blood cell count abnormal, . QUETIAPINE FUMARATE dosage: 200 MG. During the same period patient was treated with DEPAKOTE, ACTRAPID, REBOXETINE. Patient was hospitalized. Patient recovered.

Depakote Side Effects Report #5740976-3
Health Professional from FRANCE reported DEPAKOTE problem on May 09, 2008. Male patient, 62 years of age, was diagnosed with bipolar disorder, diabetes mellitus, depression and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, neutrophil count abnormal, platelet count abnormal, red blood cell abnormality, treatment noncompliance, . DEPAKOTE dosage: unknown. During the same period patient was treated with QUETIAPINE FUMARATE, INSULIN, REBOXETINE. Patient recovered.

Cyclophosphamide Side Effects Report #5753758-3
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 27, 2008. Male patient, weighting 166.0 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, lymphopenia, neutrophil count abnormal, platelet count abnormal, white blood cell count abnormal, . CYCLOPHOSPHAMIDE dosage: 1188 MG. During the same period patient was treated with PENTOSTATIN, RITUXIMAB. Patient was hospitalized. Patient recovered.

Keppra Side Effects Report #5758125-4
Physician from GERMANY reported KEPPRA problem on May 16, 2008. Male patient, 78 years of age, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, . KEPPRA dosage: unknown. Patient recovered.

Xigris Side Effects Report #5716019-4
XIGRIS problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2008. Male patient, 70 years of age, was treated with XIGRIS. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, renal failure, vomiting, . XIGRIS dosage: unknown. During the same period patient was treated with INSULIN. Patient died on 10/17/2008.


Cyclophosphamide Side Effects Report #5358321-4
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on June 14, 2007. Female patient, weighting 155.2 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, pyrexia, . CYCLOPHOSPHAMIDE dosage: 1080 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient recovered.

Mylotarg Side Effects Report #5309417-4
MYLOTARG problem was reported by a Physician from UNITED STATES on Apr 18, 2007. Male patient, 59 years of age, weighting 145.1 lb, was diagnosed with acute myeloid leukaemia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, pleural effusion, white blood cell disorder, . MYLOTARG dosage: 10.44 MG TOTAL DOSE ADMINISTERED. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient recovered.

Depakote Side Effects Report #5254388-2
Health Professional from FRANCE reported DEPAKOTE problem on Feb 21, 2007. Male patient, 62 years of age, was diagnosed with bipolar disorder, diabetes mellitus, depression and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, neutrophil count abnormal, red blood cell abnormality, . DEPAKOTE dosage: unknown. During the same period patient was treated with QUETIAPINE FUMARATE, INSULIN, REBOXETINE. Patient recovered.

Alimta Side Effects Report #5589398-9
ALIMTA problem was reported by a Health Professional from UNITED STATES on Jan 10, 2008. Female patient, 68 years of age, weighting 163.0 lb, was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, mucosal inflammation, neutrophil count abnormal, platelet disorder, rash, refusal of treatment by patient, . ALIMTA dosage: unknown. During the same period patient was treated with ERBITUX, METOPROLOL TARTRATE, LIPITOR, DIGOXIN, SYNTHROID, ROXICET, COUMADIN. Patient was hospitalized. Patient recovered.

Bortezomib Side Effects Report #5546752-9
Health Professional from UNITED STATES reported BORTEZOMIB problem on Dec 07, 2007. Male patient, 61 years of age, weighting 203.9 lb, was diagnosed with mantle cell lymphoma and was treated with BORTEZOMIB. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, haemoglobin abnormal, platelet count abnormal, rhinitis, sinusitis, . BORTEZOMIB dosage: 2.7MG D1+4 IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, DOXORUBICIN, DEXAMETHASONE, VINCRISTINE. Patient was hospitalized. Patient recovered.


Humira Side Effects Report #5560596-3
HUMIRA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 12, 2007. Male patient, weighting 208.2 lb, was diagnosed with crohn's disease and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: erectile dysfunction, haemoglobin abnormal, . HUMIRA dosage: unknown. During the same period patient was treated with MERCAPTOPURINE. Patient recovered.

Ampicillin Side Effects Report #5483379-1
Health Professional from UNITED STATES reported AMPICILLIN problem on Oct 09, 2007. Female patient, 21 years of age, weighting 180.0 lb, was diagnosed with beta haemolytic streptococcal infection, prophylaxis and was treated with AMPICILLIN. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, labour complication, postpartum haemorrhage, uterine contractions abnormal, . AMPICILLIN dosage: unknown. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #5469365-6
ALIMTA problem was reported by a Physician from UNITED STATES on Sept 18, 2007. Male patient, 87 years of age, weighting 150.0 lb, was diagnosed with mesothelioma, vitamin supplementation, prophylaxis and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: haematocrit abnormal, haemoglobin abnormal, hydropneumothorax, platelet count abnormal, pleural effusion, pulmonary embolism, white blood cell disorder, . ALIMTA dosage: 970 MG, UNK. During the same period patient was treated with VITAMIN B, FOLIC ACID, DECADRON. Patient recovered.

Fentanyl Side Effects Report #5420903-9
Consumer or non-health professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Aug 13, 2007. Female patient, weighting 149.0 lb, was diagnosed with back pain, blood pressure, diabetes mellitus, gastrooesophageal reflux disease and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, haemoglobin abnormal, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, NORVASC, CYMBALTA, PLAVIX, GLUCOPHAGE, TOPROL, ZESTRIL, NEXIUM. Patient was hospitalized. Patient recovered.

Tracleer Side Effects Report #5427664-8
TRACLEER problem was reported by a Physician from GERMANY on Aug 08, 2007. Male patient, 25 years of age, was diagnosed with pulmonary hypertension and was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: condition aggravated, haemoglobin abnormal, hypoglycaemia, thrombocytopenia, . TRACLEER dosage: unknown. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5385254-X
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on July 09, 2007. Female patient, weighting 155.2 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cough, haemoglobin abnormal, hypoxia, lung disorder, pyrexia, . CYCLOPHOSPHAMIDE dosage: 1080 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Procrit Side Effects Report #5398633-1
PROCRIT problem was reported by a Physician from UNITED STATES on June 30, 2006. Male patient, weighting 207.2 lb, was diagnosed with anaemia of malignant disease and was treated with PROCRIT. After drug was administered, patient experienced the following problems/side effects: condition aggravated, haemoglobin abnormal, oedema peripheral, red blood cell count abnormal, . PROCRIT dosage: unknown. During the same period patient was treated with DIURETICS. Patient recovered.

Cyclophosphamide Side Effects Report #5385254-X
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on July 09, 2007. Female patient, weighting 155.2 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cough, haemoglobin abnormal, hypoxia, lung disorder, pyrexia, . CYCLOPHOSPHAMIDE dosage: 1080 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Procrit Side Effects Report #5398633-1
PROCRIT problem was reported by a Physician from UNITED STATES on June 30, 2006. Male patient, weighting 207.2 lb, was diagnosed with anaemia of malignant disease and was treated with PROCRIT. After drug was administered, patient experienced the following problems/side effects: condition aggravated, haemoglobin abnormal, oedema peripheral, red blood cell count abnormal, . PROCRIT dosage: unknown. During the same period patient was treated with DIURETICS. Patient recovered.

Prednisolone Side Effects Report #5738276-0
Health Professional from UNITED KINGDOM reported PREDNISOLONE problem on May 07, 2008. Female patient, 71 years of age, was diagnosed with ischaemic heart disease prophylaxis and was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: faeces discoloured, haemoglobin abnormal, . PREDNISOLONE dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, CLOPIDOGREL, ATORVASTATIN, BISOPROLOL FUMARATE, SERETIDE, SPIRONOLACTONE, TROPIUM, VALSARTAN. Patient was hospitalized. Patient recovered.

Prednisolone Side Effects Report #5746760-9
PREDNISOLONE problem was reported by a Health Professional from UNITED KINGDOM on May 09, 2008. Female patient, 71 years of age, was diagnosed with dressler's syndrome and was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: faeces discoloured, haemoglobin abnormal, . PREDNISOLONE dosage: unknown. During the same period patient was treated with ASPIRIN, CLOPIDOGREL, ATORVASTATIN CALCIUM, BISOPROLOL FUMARATE, SERETIDE, SPIRONOLACTONE, TROPIUM, VALSARTAN. Patient was hospitalized. Patient recovered.

Prednisolone Side Effects Report #5753778-9
Consumer or non-health professional from UNITED KINGDOM reported PREDNISOLONE problem on May 08, 2008. Female patient, 71 years of age, was diagnosed with dressler's syndrome and was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: faeces discoloured, haemoglobin abnormal, . PREDNISOLONE dosage: unknown. During the same period patient was treated with CLOPIDOGREL, ATORVASTATIN, BISOPROLOL FUMARATE, SERETIDE, SPIRONOLACTONE, TROPIUM, VALSARTAN, ASPIRIN. Patient recovered.

Warfarin Side Effects Report #5601315-1
WARFARIN problem was reported by a Pharmacist from UNITED STATES on Jan 22, 2008. Male patient, 79 years of age, was diagnosed with atrial fibrillation, infection and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: cough, haematocrit abnormal, haemoglobin abnormal, haemorrhage, international normalised ratio increased, . WARFARIN dosage: 5MG EVERY DAY PO. During the same period patient was treated with AMOXICILLIN. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5638392-8
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Nov 05, 2007. Male patient, 62 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: arthralgia, asthenia, haemoglobin abnormal, myalgia, platelet count abnormal, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL ; 15 MG, 1 IN 1 D, ORAL. Patient recovered.

Fluorouracil Side Effects Report #5449883-7
FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 10, 2007. Female patient, weighting 210.3 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: dermatitis exfoliative, diarrhoea, haemoglobin abnormal, pain, platelet count abnormal, radiation skin injury, white blood cell count abnormal, . FLUOROURACIL dosage: 7800 MG. During the same period patient was treated with CISPLATIN, ERBITUX. Patient was hospitalized. Patient recovered.

Winrho Side Effects Report #5781216-9
Pharmacist from UNITED STATES reported WINRHO SDF problem on May 13, 2008. Female patient, 45 years of age, weighting 217.6 lb, was diagnosed with thrombocytopenia and was treated with WINRHO SDF. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, cardiac tamponade, haemoglobin abnormal, intravascular haemolysis, . WINRHO SDF dosage: unknown. During the same period patient was treated with POLYGAM, NEXIUM, HYDROCORTISONE, METRONIDAZOLE, VANCOMYCIN, MICAFUNGIN. Patient recovered.

Aspirin Side Effects Report #5782174-3
ASPIRIN problem was reported by a Physician from UNITED KINGDOM on Apr 22, 2008. Female patient was diagnosed with arterial restenosis, thrombosis and was treated with ASPIRIN. After drug was administered, patient experienced the following problems/side effects: fatigue, gastrointestinal pain, haemoglobin abnormal, myalgia, overdose, pyrexia, reticulocyte count increased, serum ferritin increased, . ASPIRIN dosage: unknown. During the same period patient was treated with PLAVIX. Patient recovered.

Cetuximab Side Effects Report #5344214-5
Health Professional from UNITED STATES reported CETUXIMAB problem on May 31, 2007. Male patient, 58 years of age, weighting 127.9 lb, was diagnosed with laryngeal cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: epistaxis, haemoglobin, haemoglobin abnormal, platelet disorder, white blood cell disorder, . CETUXIMAB dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5347513-6
GEMCITABINE problem was reported by a Consumer or non-health professional from UNITED STATES on June 04, 2007. Male patient, weighting 223.1 lb, was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: constipation, haematuria, haemoglobin abnormal, inadequate analgesia, nausea, neutrophil count abnormal, pain, platelet count decreased, pyrexia, . GEMCITABINE dosage: 2280 MG. During the same period patient was treated with ALIMTA, CYANOCOBALAMIN, DEXAMETHASONE, FOLIC ACID. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5366248-7
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on June 20, 2007. Female patient, weighting 155.2 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: computerised tomogram thorax abnormal, cough, haemoglobin abnormal, hypoxia, pyrexia, . CYCLOPHOSPHAMIDE dosage: 1080 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Avandamet Side Effects Report #5320199-2
AVANDAMET problem was reported by a Pharmacist from UNITED STATES on May 07, 2007. Female patient, 53 years of age, weighting 270.5 lb, was treated with AVANDAMET. After drug was administered, patient experienced the following problems/side effects: full blood count abnormal, haematocrit abnormal, haemoglobin abnormal, iron binding capacity total abnormal, iron deficiency anaemia, red blood cell count abnormal, weight increased, . AVANDAMET dosage: unknown. During the same period patient was treated with SULFONYLUREA, JANUVIA, GLUCOTROL, HYDROCHLOROTHIAZIDE, SIMVASTATIN, TENORMIN, ASPIRIN. Patient recovered.

Oxandrolone Side Effects Report #5322030-8
Health Professional from UNITED STATES reported OXANDROLONE problem on May 08, 2007. Female patient, 51 years of age, weighting 101.0 lb, was diagnosed with weight decreased and was treated with OXANDROLONE. After drug was administered, patient experienced the following problems/side effects: dehydration, haemoglobin abnormal, neutropenia, platelet count abnormal, pyrexia, white blood cell count abnormal, . OXANDROLONE dosage: 10 MG BID PO. Patient was hospitalized. Patient recovered.

Topotecan Side Effects Report #5333451-1
TOPOTECAN problem was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2007. Female patient, weighting 155.9 lb, was treated with TOPOTECAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, fatigue, haemoglobin abnormal, nausea, vomiting, . TOPOTECAN dosage: 8.9 MG. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5297709-7
Health Professional from UNITED STATES reported VELCADE problem on Apr 12, 2007. Male patient, weighting 210.0 lb, was diagnosed with non-small cell lung cancer and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: bronchospasm, disease progression, haemoglobin abnormal, haemoptysis, performance status decreased, platelet count abnormal, pulmonary embolism, pulmonary haemorrhage, pyrexia, . VELCADE dosage: 1.3MG/M2 D1,D8 Q21DAY IV. During the same period patient was treated with GEMCITABINE, CARBOPLATIN. Patient died on 04/01/2007.

Aleve Side Effects Report #5338778-5
ALEVE problem was reported by a Physician from UNITED STATES on Mar 28, 2006. Male patient, 73 years of age, weighting 170.0 lb, was diagnosed with arthritis, non-small cell lung cancer and was treated with ALEVE. After drug was administered, patient experienced the following problems/side effects: diarrhoea haemorrhagic, duodenal ulcer, haemoglobin abnormal, . ALEVE dosage: 200 MG, QID, ORAL. During the same period patient was treated with TAXOTERE, MOBIC. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5284401-8
Health Professional from UNITED STATES reported VELCADE problem on Mar 30, 2007. Male patient, weighting 210.0 lb, was diagnosed with non-small cell lung cancer and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: bronchospasm, chest pain, haemoglobin abnormal, platelet count abnormal, pulmonary embolism, pulmonary haemorrhage, pyrexia, . VELCADE dosage: 1.3 MG/M2 D1,D8 Q 21DAY IV. During the same period patient was treated with GEMCITABINE, CARBOPLATIN. Patient was hospitalized. Patient recovered.